These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9516506)
21. [Characterization of hepatic neoplasms: contribution of magnetic resonance]. Gualdi GF; Volpe A; Polettini E; Ceroni AM; Melone A; Casciani E Clin Ter; 1994 Jul; 145(7):53-63. PubMed ID: 7955951 [TBL] [Abstract][Full Text] [Related]
22. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040 [TBL] [Abstract][Full Text] [Related]
23. Spectrum of multilocular cystic hepatic lesions: CT and MR imaging findings with pathologic correlation. Qian LJ; Zhu J; Zhuang ZG; Xia Q; Liu Q; Xu JR Radiographics; 2013; 33(5):1419-33. PubMed ID: 24025933 [TBL] [Abstract][Full Text] [Related]
25. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125 [TBL] [Abstract][Full Text] [Related]
26. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. Brancatelli G; Baron RL; Peterson MS; Marsh W AJR Am J Roentgenol; 2003 Apr; 180(4):1007-14. PubMed ID: 12646446 [TBL] [Abstract][Full Text] [Related]
27. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674 [TBL] [Abstract][Full Text] [Related]
29. Hepatic capsular retraction: unusual finding of cavernous hemangioma. Lee SH; Park CM; Cheong IJ; Kwak MS; Cha SH; Choi SY; Kim CH J Comput Assist Tomogr; 2001; 25(2):231-3. PubMed ID: 11242218 [TBL] [Abstract][Full Text] [Related]
30. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314 [TBL] [Abstract][Full Text] [Related]
31. Imaging of benign and malignant focal liver lesions. Martin DR; Semelka RC Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):785-802, vi-vii. PubMed ID: 11694438 [TBL] [Abstract][Full Text] [Related]
32. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. Jones EC; Chezmar JL; Nelson RC; Bernardino ME AJR Am J Roentgenol; 1992 Mar; 158(3):535-9. PubMed ID: 1738990 [TBL] [Abstract][Full Text] [Related]
33. Siphoning effect and steal phenomenon combined to focal hepatic lesions on spiral CT. Four cases report. Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N Radiol Med; 2002 Mar; 103(3):267-74. PubMed ID: 11976625 [No Abstract] [Full Text] [Related]
34. Low field magnetic resonance imaging of focal hepatic masses at 0.02 T. Ekelund L; Athlin L Acta Radiol; 1989; 30(6):591-5. PubMed ID: 2561078 [TBL] [Abstract][Full Text] [Related]
35. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Khalil HI; Patterson SA; Panicek DM Radiology; 2005 Jun; 235(3):872-8. PubMed ID: 15833992 [TBL] [Abstract][Full Text] [Related]
36. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Lee HY; Lee JM; Kim SH; Shin KS; Lee JY; Han JK; Choi BI Clin Imaging; 2008; 32(4):287-95. PubMed ID: 18603184 [TBL] [Abstract][Full Text] [Related]
37. Supplement value of magnetic resonance imaging in small hepatic lesion (< or = 20 mm) detected on routine computed tomography. Phongkitkarun S; Srianujata T; Jatchavala J J Med Assoc Thai; 2009 May; 92(5):677-86. PubMed ID: 19459531 [TBL] [Abstract][Full Text] [Related]
38. The distinction between benign and malignant liver tumors on sonography: value of a hypoechoic halo. Wernecke K; Vassallo P; Bick U; Diederich S; Peters PE AJR Am J Roentgenol; 1992 Nov; 159(5):1005-9. PubMed ID: 1329454 [TBL] [Abstract][Full Text] [Related]
39. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575 [TBL] [Abstract][Full Text] [Related]
40. Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress. Glazer GM; Aisen AM; Francis IR; Gyves JW; Lande I; Adler DD Radiology; 1985 May; 155(2):417-20. PubMed ID: 3983393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]